229 related articles for article (PubMed ID: 10694287)
1. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease.
Freeman HJ; Freeman KJ
Can J Gastroenterol; 2000 Feb; 14(2):138-43. PubMed ID: 10694287
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent aseptic osteonecrosis in Crohn's disease - extraintestinal manifestation or steroid related complication?].
Lanyi B; Dienes HP; Kruis W
Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1944-7. PubMed ID: 16123897
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous osteonecrosis in Crohn's disease.
Freeman HJ; Owen D; Millan M
Can J Gastroenterol; 2000 Dec; 14(11):951-4. PubMed ID: 11125186
[TBL] [Abstract][Full Text] [Related]
4. Meckel's diverticulum in Crohn's disease.
Freeman HJ
Can J Gastroenterol; 2001 May; 15(5):308-11. PubMed ID: 11381298
[TBL] [Abstract][Full Text] [Related]
5. Multifocal osteonecrosis in adolescents with Crohn's disease: a complication of therapy?
Shapiro SC; Rothstein FC; Newman AJ; Fletcher B; Halpin TC
J Pediatr Gastroenterol Nutr; 1985 Jun; 4(3):502-6. PubMed ID: 4020583
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis in a patient with Crohn's disease unrelated to corticosteroid use.
Khan A; Illiffe G; Houston DS; Bernstein CN
Can J Gastroenterol; 2001 Nov; 15(11):765-8. PubMed ID: 11727007
[TBL] [Abstract][Full Text] [Related]
7. Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
Watanabe Y; Miyoshi N; Fujino S; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Doki Y; Mori M; Mizushima T
Dig Dis Sci; 2019 Aug; 64(8):2280-2285. PubMed ID: 30806860
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
[TBL] [Abstract][Full Text] [Related]
9. [Epiphysis-metaphysis bone ischemia in hemorrhagic rectocolitis and Crohn's disease].
Reimund JM; Sibilia J; Durckel J; Brunet B; Loth F; Kuntz JL; Duclos B; Baumann R
Gastroenterol Clin Biol; 1998; 22(6-7):634-8. PubMed ID: 9762335
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of metastatic Crohn's disease.
Schneider SL; Foster K; Patel D; Shwayder T
Pediatr Dermatol; 2018 Sep; 35(5):566-574. PubMed ID: 29952016
[TBL] [Abstract][Full Text] [Related]
11. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
12. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
[TBL] [Abstract][Full Text] [Related]
13. Steroid-dependent Crohn's disease.
Sandborn WJ
Can J Gastroenterol; 2000 Sep; 14 Suppl C():17C-22C. PubMed ID: 11023556
[TBL] [Abstract][Full Text] [Related]
14. Enteral nutritional therapy for inducing remission of Crohn's disease.
Zachos M; Tondeur M; Griffiths AM
Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
[TBL] [Abstract][Full Text] [Related]
15. Osteomyelitis and osteonecrosis in inflammatory bowel disease.
Freeman HJ
Can J Gastroenterol; 1997 Oct; 11(7):601-6. PubMed ID: 9395761
[TBL] [Abstract][Full Text] [Related]
16. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
[TBL] [Abstract][Full Text] [Related]
17. The effect of infliximab on extraintestinal manifestations of Crohn's disease.
Kaufman I; Caspi D; Yeshurun D; Dotan I; Yaron M; Elkayam O
Rheumatol Int; 2005 Aug; 25(6):406-10. PubMed ID: 15309501
[TBL] [Abstract][Full Text] [Related]
18. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Kugathasan S; Denson LA; Walters TD; Kim MO; Marigorta UM; Schirmer M; Mondal K; Liu C; Griffiths A; Noe JD; Crandall WV; Snapper S; Rabizadeh S; Rosh JR; Shapiro JM; Guthery S; Mack DR; Kellermayer R; Kappelman MD; Steiner S; Moulton DE; Keljo D; Cohen S; Oliva-Hemker M; Heyman MB; Otley AR; Baker SS; Evans JS; Kirschner BS; Patel AS; Ziring D; Trapnell BC; Sylvester FA; Stephens MC; Baldassano RN; Markowitz JF; Cho J; Xavier RJ; Huttenhower C; Aronow BJ; Gibson G; Hyams JS; Dubinsky MC
Lancet; 2017 Apr; 389(10080):1710-1718. PubMed ID: 28259484
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
